Karlafti, E.; Didangelos, T.; Benioudakis, E.; Kotzakioulafi, E.; Kaiafa, G.; Kotsis, V.; Ziakas, A.; Doumas, M.; Goulas, A.; Savopoulos, C.
Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study. Endocrines 2022, 3, 43-52.
https://doi.org/10.3390/endocrines3010004
AMA Style
Karlafti E, Didangelos T, Benioudakis E, Kotzakioulafi E, Kaiafa G, Kotsis V, Ziakas A, Doumas M, Goulas A, Savopoulos C.
Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study. Endocrines. 2022; 3(1):43-52.
https://doi.org/10.3390/endocrines3010004
Chicago/Turabian Style
Karlafti, Eleni, Triantafyllos Didangelos, Emmanouil Benioudakis, Evangelia Kotzakioulafi, Georgia Kaiafa, Vasileios Kotsis, Antonios Ziakas, Michail Doumas, Antonios Goulas, and Christos Savopoulos.
2022. "Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study" Endocrines 3, no. 1: 43-52.
https://doi.org/10.3390/endocrines3010004
APA Style
Karlafti, E., Didangelos, T., Benioudakis, E., Kotzakioulafi, E., Kaiafa, G., Kotsis, V., Ziakas, A., Doumas, M., Goulas, A., & Savopoulos, C.
(2022). Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study. Endocrines, 3(1), 43-52.
https://doi.org/10.3390/endocrines3010004
